Skip to content
  • My Accountmy account
  • Search
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment
    Protocols

    • Protocols

      Read about strategies to prevent and treat conditions like COVID-19, insulin resistance, RSV, long COVID, and more.

      Learn More
      Prevention

      Boost your immune system, clear your body of spike protein, and learn the benefits of intermittent fasting.

      • EAT WELL
      • I-PREVENT Vaccine Injury
      • See all Prevention Protocols
      Treatment

      At-home and hospital treatment plans for COVID, insulin resistance, sepsis, RSV and flu.

      • I-CARE Early At Home Treatment
      • I-CARE RSV and Flu Treatment
      • See all Treatment Protocols
      Recovery

      Approaches to managing symptoms from long COVID and long Vax.

      • I-RECOVER Post Vaccine Treatment
      • I-RECOVER Long Covid
      • See all Recovery Protocols
  • Medical
    Evidence
    • Reviews & Monographs

      In-depth academic pieces presenting original research, analysis, and evidence on complex conditions.

      Cancer Care
    • Studies

      A comprehensive listing of all research, studies, authors and sources cited in each FLCCC prevention and treatment protocol for COVID-19

      Learn More
    • Lectures

      Watch FLCCC doctors speak at international medical conferences, professional seminars and symposiums.

      Learn More
    • Senate Testimony

      Watch Dr. Pierre Kory testify before the U.S. Senate regarding FLCCC protocols to treat COVID-19.

      Learn More
  • COVID
    Resources

    • Wondering where to begin?

      Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

      get started
      Patient Resources
      • Find a Provider
      • Find a Pharmacy
      • Tools & Guides
      • Testimonials
      • Hospital Guide
      Practitioner Resources
      • Efficacy of Ivermectin
      • Informed Consent
      • Nurses for FLCCC
      • Join the Alliance
      • Education on Demand
  • Education &
    Events

    • About the education portal

      FLCCC’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

      Events

      Our twice-yearly conferences bring top experts from a variety of fields together to learn, share, and network with each other.

      • Learn More
      Education on Demand

      Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from FLCCC educational programs.

      • My Content
      • Explore Courses
  • News &
    Webinars
    • Latest Updates

      Stay up-to-date with the latest news from our fast-moving field.

      View
    • Blog

      Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from FLCCC.

      Read Now
    • Weekly Webinars

      Sign up for our webinars, every Wednesday at 7pm ET, offering the latest information on therapeutics and treatments and answering audience questions.

      Learn More
    • FLCCC in the News

      Read media coverage of FLCCC from around the world.

      View
  • About
    FLCCC

    • About the FLCCC

      Learn about the history of FLCCC, our mission and vision, and how you can get involved.

      learn more
      • Our Physicians
      • Our Partners
      • Advocacy
      • FAQ
      • Terms and Conditions
      • Impact Reports
      • Annual Reports
      • Support Us
      • Shop our Store
      • Connect with Us
  • Donate
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
FLCCC | Front Line COVID-19 Critical Care Alliance
  • Treatment Protocols
  • Find a Provider
  • Find a Pharmacy
  • Medical Evidence
    • Cancer Care
    • Studies
    • Lectures
    • Senate Testimony
  • COVID Resources
    • Get Started
    • Tools & Guides
    • Ivermectin
    • Hospital Guide
    • Nurses for FLCCC
    • Join The Alliance
  • Education & Events
    • Educational Conference
    • Education on Demand
    • My Content
  • News & Webinars
    • Latest Updates
    • FLCCC Blog
    • Weekly Webinars
    • FLCCC in the News
  • About The FLCCC
  • FAQ
  • Connect with Us
  • Donate
  • Cart
Donate

References

Categories

I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (171)

Tags

ACE2 protein (10) acute respiratory distress syndrome (13) Alopecia (7) Anti-inflammatory (8) Antidepressants (9) Ascorbic Acid (9) autoantibodies (10) autophagy (24) Calcifediol (6) Cancer (9) Corticosteroids (8) COVID-19 (255) COVID-19 Vaccines (8) Curcumin (8) Cytokines (10) Depression (10) Famotidine (14) flavonoids (5) Glucocorticoids (6) Hydroxychloroquine (12) Hyperbaric Oxygen Therapy (9) Inflammation (14) ivermectin (46) long COVID (21) Mast Cells (8) Melatonin (20) molnupiravir (5) N-Acetylcysteine (6) Non-Invasive Brain Stimulation (8) Omicron (7) Oxytocin (8) Pneumonia (8) quercetin (15) resveratrol (5) SARS-CoV-2 (72) SARS-CoV-2 mRNA Vaccines (7) Sepsis (15) spermidine (11) Spike Protein (10) Thrombosis (9) Tinnitus (12) Valproic Acid (5) Vitamin C (16) Vitamin D (9) Zinc (12)
  • Reference: Prescription of ivermectin or hydroxychloroquine as off-label medicines for the prevention and treatment of Covid-19.

    Published On: October 14, 2021

    Authors: Peterson DJ. PMID: Abstract Keywords: Source: https://ago.nebraska.gov/sites/ago.nebraska.gov/files/docs/opinions/21-017_0.pdf Archive: https://archive.is/EoVhB

    Categories: I-CARE Early Covid, MATH+

    Tags: COVID-19, Hydroxychloroquine, ivermectin

  • Reference: Comparative effectiveness of famotidine in hospitalized COVID-19 patients

    Published On: April 11, 2021

    Famotidine has been posited as a potential treatment for coronavirus disease 2019 (COVID-19). We compared the incidence of COVID-19 outcomes (i.e., death and death or intensive services use) among hospitalized famotidine users vs proton pump inhibitors (PPIs) users, hydroxychloroquine users, or famotidine nonusers separately.

    Categories: MATH+

    Tags: COVID-19, Famotidine, Hydroxychloroquine

  • Reference: Early outpatient treatment of symptomatic, High-Risk Covid-19 patients that should be rampedup immediately as key to the pandemic crisis

    Published On: November 2, 2020

    More than 1.6 million Americans have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more than 10 times that number carry antibodies to it.

    Categories:

    Tags: azithromycin, Coronavirus, COVID-19, doxycycline, Hydroxychloroquine, SARS-CoV-2, Zinc

  • Reference: A randomized trial of ivermectin-doxycycline and hydrochloroquine-azithromycin therapy on COVID-19 patients.

    Published On: July 14, 2020

    Authors: Chowdhury AT, Shahabz M, Karim MR, Islam J, Guo D, He D. DOI: https://doi.org/10.21203/rs.3.rs-38896/v1 Abstract Background The worldwide COVID-19 pandemic was caused by a newly discovered Coronavirus. The treatment methods for COVID-19 are emerging and rapidly evolving. Existing drugs, including Ivermectin and Hydroxychloroquine, offer the hope of effective treatment in early disease. In this [...]

    Categories: I-CARE Early Covid, MATH+

    Tags: COVID-19, Doxycyline, Hydroxychloroquine, ivermectin

  • Reference: A randomized Phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in pancreatic cancer patients.

    Published On: July 1, 2020

    Authors: Zeh HJ, Bahary N, Boone BA, Singh AD, Normolle Dp, Hogg ME PMID: 32156749 PMCID: PMC8086597 DOI: 10.1158/1078-0432.CCR-19-4042 Abstract Purpose: We hypothesized that autophagy inhibition would increase response to chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We performed a randomized controlled trial to assess the autophagy inhibitor hydroxychloroquine in combination with [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autophagy, Cancer, Hydroxychloroquine

  • Reference: A review on possible modes of chloroquine/hydroxychloroquine: repurposing against SARS-CoV-2 (COVID-19) pandemic.

    Published On: May 22, 2020

    Authors: Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa MG PMID: 32450198 PMCID: PMC7243790 DOI: 10.1016/j.ijantimicag.2020.106028 Abstract Chloroquine (CQ) and its analogue hydroxychloroquine (HCQ) have long been used worldwide as frontline drugs for the treatment and prophylaxis of human malaria. Since the first reported cases in Wuhan, China, in late December 2019, humans have [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: COVID-19, Hydroxychloroquine, SARS-CoV-2

  • Reference: Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

    Published On: December 17, 2019

    Authors: de Moreuil C, Alavi Z, Pasquier E PMID: 31633823 PMCID: PMC6983516 DOI: 10.1111/bcp.14131 Abstract Recurrent miscarriage (RM) and vasculoplacental disorders, such as preeclampsia (PE), affect women of childbearing age worldwide. Vascular endothelial dysfunction and immunological impairment are associated with both RM and PE. To date, there is no effective or optimal therapeutic approach for [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: Hydroxychloroquine, Miscarriage, Preeclampsia

  • Reference: Expanding horizons for clinical applications of chloroquine, hydroxychloroquine and related structural analogues.

    Published On: November 25, 2019

    Authors: Shukla AM, Shukla AW PMID: 31844421 PMCID: PMC6905642 DOI: 10.7573/dic.2019-9-1 Abstract Several experimental and clinical studies have transformed the traditional antimalarial role of chloroquine (CHQ) and related structural analogues to potent therapeutic agents for a host of nonmalarial indications. The expanding clinical applicability for these drugs includes rheumatological and cardiovascular disorders (CVD), chronic kidney [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: Chloroquine, Hydroxychloroquine

  • Reference: The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers. A systematic review and meta-analysis.

    Published On: November 9, 2018

    Authors: Xu R, Ji Z, Xu C, Zhu J PMID: 30431566 PMCID: PMC6257684 doi: 10.1097/MD.0000000000012912 Abstract Background: Autophagy is a mechanism which relies on lysosomes for clearance and recycling of abnormal proteins or organelles. Many studies have demonstrated that the deregulation of autophagy is associated with the development of various diseases including cancer. The use [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autophagy, Cancer, Hydroxychloroquine

  • Reference: Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic and neurological diseases: A mini review.

    Published On: August 3, 2018

    Authors: Plantone D, Koudriavtseva T PMID: 29737455 DOI: 10.1007/s40261-018-0656-y Abstract The process of finding new therapeutic indications for currently used drugs, defined as 'repurposing', is receiving growing attention. Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious (HIV, Q fever, Whipple's disease, fungal infections), [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: Chloroquine, Hydroxychloroquine

12Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]